Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index; 51 of the 71 sources its claims cite were checked for support.
Abstract
The pronounced skin tropism and pan-antifungal resistance of Candida auris pose a serious global health threat. A key question in C. auris biology is how clinical isolates acquire amphotericin B resistance. Here we demonstrate that a carbonic sensing pathway (CSP) contributes to amphotericin B resistance by modulating mitochondrial energy functions in clinical C. auris isolates. Integrated transcriptomics and proteomics identify the carbonic anhydrase Nce103 and its transcription factors Rca1 and Efg1 as important regulatory components of the CSP. The conversion of CO 2 into bicarbonate sustains energy metabolism required for colonization and fitness on human skin and in nutrient-limited microenvironments. We also show that bacterial skin colonizers engage urease to release CO 2 that sustains C. auris fitness and skin colonization. These findings highlight therapeutic options to re-sensitize C. auris to antifungal treatments, as well as to prevent skin colonization by blocking the CSP.
Overview
CoChat Summary
TL;DR
This study identifies a carbonic sensing pathway (CSP) centered on Nce103, Rca1, and Efg1 as a driver of both amphotericin B resistance and skin colonization in *Candida auris*. The authors show that CO2/bicarbonate-dependent metabolism supports fungal fitness, and that CO2 released by urease-positive skin bacteria can promote *C. auris* growth.
Key findings
- In clinical *C. auris* isolates, deleting RCA1 reduced amphotericin B MIC by 2-fold to 4-fold, while deleting EFG1 reduced MIC by 2-fold; the rca1∆efg1∆ double mutant did not further worsen susceptibility, consistent with an epistatic CSP.
- Deleting NCE103 caused severe fitness defects in ambient air, and the nce103∆ mutant showed the same amphotericin B MIC as rca1∆ in 1.5% CO2; 5.5% CO2 fully restored amphotericin B resistance in all strains tested.
- In phenotype assays, deleting RCA1, EFG1, or NCE103 increased sensitivity to SDS, NaCl, H2O2, and antimycin A, while NCE103 overexpression reduced susceptibility to NaCl, H2O2, antimycin A, MMS, and rapamycin.
- In skin colonization models, nce103∆ showed 10- to 100-fold lower burden than wild type on mouse skin after 48 h and on human skin ex vivo after 24 h; rca1∆ and efg1∆ also showed 10- to 100-fold reduced colonization of mouse and human skin.
- Urease-positive bacteria, specifically Proteus mirabilis and Klebsiella pneumoniae, significantly enhanced growth of CSP mutants in vitro, but this effect was lost with urease-negative bacterial controls.
Methods
- The study combined shotgun proteomics and RNA-seq/transcriptomics across resistant and sensitive clinical *C. auris* isolates to identify pathways linked to antifungal resistance.
- Functional validation used gene deletions, overexpression constructs, CRISPR–Cas9-based NCE103 deletion, spotting assays, MIC and checkerboard assays, lipidomics, and mouse/human skin colonization models.
- Mouse work included intradermal infection, skin colonization, and systemic infection assays in C57BL/6 mice; human skin assays used abdominal skin samples from three independent donors.
Limitations
- The paper states that the effect of skin-dwelling bacteria is supported by in vitro co-culture assays and suggests a role for microbiome-derived CO2, but the causal contribution in vivo is not directly established.
- The authors note that Nce103-mediated changes in lipid composition were not clearly detectable by their lipidomics, and some lipid/fluidity findings were variable across independent replicates.
- Evident from the text: the study relies on a limited number of human skin donors (three independent donors) and mouse groups (5–11 mice per group), which may constrain generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
33 Valid · 4 Not valid · 9 Not checked · 123 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, major effectors or sensing mechanisms implicated in antifungal resistance escaped discovery15,16.”
§ Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103 > Results > Proteomics reveals multidrug resistance mechanisms in C. auris Transcriptomics of MDR strains versus drug-sensitive clinical isolates revealed numerous genes implicated in carboxylic acid metabolism, mitochondrial function, translation and membrane transports as critical hallmarks of antifungal resistance traits in C. auris15–17. However, major effectors or sensing mechanisms implicated in antifungal resistance escaped discovery15,16. Hence, we hypothesized that proteomics may identify key pathways involved in C. auris MDR traits from differentially abundant proteins (DAPs). We subjected cell-free extracts from resistant (R) (462/P/14-R1) and sensitive (S) (2431/P/16–S) C. auris strains15,17 (Fig. 1a,b) to shotgun proteomics. The data were then integrated with available RNA-sequencing (RNA-seq) datasets of strains with partially overlapping antifungal susceptibility profiles (R1, 1133/P/13R–R2 and S). As expected, several membrane transporter families were highly enriched in resistant C. auris strains (Fig. 1c and Extended Data Fig. 1a,b), including the Cdr1 multidrug efflux ATP-binding cassette (ABC) transporter, the Mdr1 major facilitator and the putative phosphatidylinositol transfer protein Pdr16 (ref. 18), all of which cause clinical azole resistance16,19,20. In addition, the isolates R1 and R2, but not the S strain, carried the mutational hotspot S639F in the Fks1 glucan synthase (Extended Data Fig. 1c)15,21, thus explaining pronounced echinocandin resistance traits in R1 and R2. The overlay of proteo-transcriptomics datasets (Extended Data Fig. 1d–f) revealed numerous proteins, of which we chose several high-abundance factors for further validation, but at least ablation of PGA31.2, PHR1 and SMF12 did not change in minimal inhibitory concentrations (MICs) for all four antifungal classes (Extended Data Fig. 2a). NCE103 (B9J08_000363) encoding a carbonic anhydrase that converts CO2 into bicarbonate (HCO3−) was the most abundant protein in R1 relative to S (Fig. 1d). In addition, the transcription factor Rca1, a key regulator of NCE103, was also enriched in strain R1 (Fig. 1d). Gene Ontology term analysis revealed the enrichment of carboxylic acid metabolism and cell redox homeostasis in R1 (Fig. 1e), implicating a potential link between drug resistance and mitochondrial function, the main cellular location of carboxylic acid metabolism22. In other fungal species, bicarbonate plays critical roles in energy metabolism and morphogenesis, as it is acting through the cyclic adenosine monophosphate–dependent protein kinase A (cAMP/PKA) signaling pathway that converges at the regulator Efg1 (refs. 23–25). Taking these together, we hypothesized that the Rca1–Nce103–Efg1 axis is vital to control antifungal susceptibility (Fig. 1f).
What the sources say
- Could not verifycites [15] Jenull, S. et al. Transcriptomics and phenotyping define genetic signatures associated with echinocandin resistance in Candida auris. mBio 13, e00799-22 (2022). sourceExperimental — accuracy not yet measured
The Introduction says that mechanisms behind distinct biological properties of C. auris isolates remain elusive, but it does not say that major antifungal-resistance effectors or sensing mechanisms escaped discovery. The Discussion identifies FKS mutations as a major mechanism of clinical echinocandin resistance and discusses possible additional mechanisms; neither passage establishes the specific claim (pages unavailable in our copy). (LLM, conf=0.72)
- Disputedcites [16] Jenull, S. et al. Transcriptome signatures predict phenotypic variations of Candida auris. Front. Cell. Infect. Microbiol. 11, e662563 (2021). sourceExperimental — accuracy not yet measured
The Results section (‘Transcriptional Aberrations of Key Players Determine Fungal Phenotypic Identities’; page unavailable) reports identifying and functionally validating CDR1 as an effector of azole resistance in Candida auris. Rather than saying major effectors escaped discovery, the paper says deleting CDR1 restored azole sensitivity in the resistant isolate; it does not make a corresponding claim about undiscovered sensing mechanisms. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Although lanosterol proportions increased by AMB exposure, differences in sterol composition between R and S strains were insignificant, consistent with a recent report12.”
§ Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103 > Results > Deletion of NCE103 has marginal effects on lipidomes
What the sources say
- Disputedcites [12] Chauhan, A. et al. Multi-omics analysis of experimentally evolved Candida auris isolates reveals modulation of sterols, sphingolipids, and oxidative stress in acquired amphotericin B resistance. Mol. Microbiol. 124, 154–172 (2025). sourceExperimental — accuracy not yet measured
The Results section ('HSX11 levels do not directly impact AmB susceptibility'; page unavailable) says sterol analysis found accumulation of cholesta-5,7,24-trienol in the resistant B1.1 strain. It also explicitly describes B1.1 as having an altered sterol profile, rather than reporting that sterol-composition differences between resistant and susceptible strains were insignificant. The paper does not provide a statistical comparison for the citing sentence’s particular strains. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“including the Cdr1 multidrug efflux ATP-binding cassette (ABC) transporter, the Mdr1 major facilitator and the putative phosphatidylinositol transfer protein Pdr16 (ref. 18), all of which cause clinical azole resistance16,19,20.”
§ Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103 > Results > Proteomics reveals multidrug resistance mechanisms in C. auris Transcriptomics of MDR strains versus drug-sensitive clinical isolates revealed numerous genes implicated in carboxylic acid metabolism, mitochondrial function, translation and membrane transports as critical hallmarks of antifungal resistance traits in C. auris15–17. However, major effectors or sensing mechanisms implicated in antifungal resistance escaped discovery15,16. Hence, we hypothesized that proteomics may identify key pathways involved in C. auris MDR traits from differentially abundant proteins (DAPs). We subjected cell-free extracts from resistant (R) (462/P/14-R1) and sensitive (S) (2431/P/16–S) C. auris strains15,17 (Fig. 1a,b) to shotgun proteomics. The data were then integrated with available RNA-sequencing (RNA-seq) datasets of strains with partially overlapping antifungal susceptibility profiles (R1, 1133/P/13R–R2 and S). As expected, several membrane transporter families were highly enriched in resistant C. auris strains (Fig. 1c and Extended Data Fig. 1a,b), including the Cdr1 multidrug efflux ATP-binding cassette (ABC) transporter, the Mdr1 major facilitator and the putative phosphatidylinositol transfer protein Pdr16 (ref. 18), all of which cause clinical azole resistance16,19,20. In addition, the isolates R1 and R2, but not the S strain, carried the mutational hotspot S639F in the Fks1 glucan synthase (Extended Data Fig. 1c)15,21, thus explaining pronounced echinocandin resistance traits in R1 and R2. The overlay of proteo-transcriptomics datasets (Extended Data Fig. 1d–f) revealed numerous proteins, of which we chose several high-abundance factors for further validation, but at least ablation of PGA31.2, PHR1 and SMF12 did not change in minimal inhibitory concentrations (MICs) for all four antifungal classes (Extended Data Fig. 2a). NCE103 (B9J08_000363) encoding a carbonic anhydrase that converts CO2 into bicarbonate (HCO3−) was the most abundant protein in R1 relative to S (Fig. 1d). In addition, the transcription factor Rca1, a key regulator of NCE103, was also enriched in strain R1 (Fig. 1d). Gene Ontology term analysis revealed the enrichment of carboxylic acid metabolism and cell redox homeostasis in R1 (Fig. 1e), implicating a potential link between drug resistance and mitochondrial function, the main cellular location of carboxylic acid metabolism22. In other fungal species, bicarbonate plays critical roles in energy metabolism and morphogenesis, as it is acting through the cyclic adenosine monophosphate–dependent protein kinase A (cAMP/PKA) signaling pathway that converges at the regulator Efg1 (refs. 23–25). Taking these together, we hypothesized that the Rca1–Nce103–Efg1 axis is vital to control antifungal susceptibility (Fig. 1f).
What the sources say
- Could not verifycites [16] Jenull, S. et al. Transcriptome signatures predict phenotypic variations of Candida auris. Front. Cell. Infect. Microbiol. 11, e662563 (2021). sourceExperimental — accuracy not yet measured
In the citing sentence, ref. 18 is attached to the identification of Pdr16; the claim that all three proteins cause clinical azole resistance is followed by refs. 16, 19 and 20. Our copy’s Results section discusses CDR1 and MDR1, but a search for PDR16 and phosphatidylinositol transfer protein found no passage identifying Pdr16 or addressing its role in azole resistance. (LLM, conf=0.74)
- Partly supportedcites [19] Li, J., Coste, A. T., Bachmann, D., Sanglard, D. & Lamoth, F. Deciphering the Mrr1/Mdr1 pathway in azole resistance of Candida auris. Antimicrob. Agents Chemother. 66, e0006722 (2022). sourceExperimental — accuracy not yet measured
The Results and Discussion (pages unavailable) support roles for Cdr1 and the Mrr1–Mdr1 pathway in C. auris azole susceptibility. They do not address Pdr16, and the Discussion says the susceptibility change caused by Mrr1–Mdr1 alone remained below proposed clinical resistance breakpoints. Thus this source does not establish that all three cause clinical azole resistance. (LLM, conf=0.88)
- Partly supportedcites [20] Kim, S. H. et al. Genetic analysis of Candida auris implicates Hsp90 in morphogenesis and azole tolerance and Cdr1 in azole resistance. mBio https://doi.org/10.1128/mbio.02529-18 (2019). sourceExperimental — accuracy not yet measured
The Results section, “Hsp90-independent fluconazole resistance is mediated in part by Cdr1” (page not provided), reports that deleting CDR1 reduced the fluconazole MIC eightfold in a C. auris isolate, supporting Cdr1’s role in azole resistance. The cited passages do not establish that Mdr1 or Pdr16 cause clinical azole resistance. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Indeed, using IGV tool (version 2.16.2)27, we discovered a single non-synonymous nucleotide polymorphism RCA1, yielding a truncated Rca1Y110* variant lacking a the essential bZIP region.”
§ Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103 > Results > Rca1 and Efg1 controls AMB susceptibility across clinical isolates Orthologues of the carbonic anhydrase basic leucine zipper (bZIP) regulator Rca1 and the helix–turn–helix / asexual–phases–specific (HTH-APSES)-type transcription factor Efg1 are only present in Candida spp. and Saccharomyces spp. genomes but not in Aspergillus fumigatus (Extended Data Fig. 2b,c). Thus, we first deleted RCA1 and EFG1 in different C. auris clinical isolates showing elevated MICs of ≥1 µg ml−1 for AMB (Fig. 2a and Extended Data Fig. 3a). Indeed, loss of RCA1 caused 2-fold and 4-fold reductions of the AMBMIC in a strain from clade III (AR384) and in different MDR strains from clade I, respectively. Deletion of EFG1 resulted in a 2-fold reduction of the MIC for AMB in both clade I and clade III strains. Surprisingly, efg1∆ and the rca1∆efg1∆ double mutant showed a 2-fold increase in MICs compared to the rca1∆ deletion (Fig. 2a). This may result from rewiring multiple downstream pathways influencing AMB tolerance or to the flocculation phenotype of efg1∆ often observed in clinical isolates (Extended Data Fig. 3b)26. Moreover, both rca1∆ and efg1∆ mutants showed slightly increased susceptibility to 5-fluorocytosine, although not significant to caspofungin or voriconazole (Extended Data Fig. 3c). To further verify the role of the CSP, MIC experiments were repeated at high and low CO2 to simulate the varying CO2 levels on the skin and within deeper tissues, respectively. Remarkably, the rca1∆, efg1∆, and the sensitive strain S entirely restored AMBR in the presence of 5.5% CO2 (Fig. 2a and Extended Data Fig. 3a) relative to the AMBS in ambient air (~0.04% CO2). Consequently, both Rca1 and Efg1 modulate AMB susceptibility through carbonic sensing. The simultaneous deletion of RCA1 and EFG1 showed their epistatic relationship. AMB susceptibility and CO2-sensing phenotypes were similar in strain S and rca1∆ mutants (Fig. 2a), suggesting genetic mutations in RCA1. Indeed, using IGV tool (version 2.16.2)27, we discovered a single non-synonymous nucleotide polymorphism RCA1, yielding a truncated Rca1Y110* variant lacking a the essential bZIP region. In addition, the Rca1Y110* variant was non-functional and unstable, as proteomics failed to detect any Rca1-derived peptides from strain S (Fig. 2b). Overall, the data indicated that existing loss-of-function mutation in RCA1 resensitized C. auris clinical isolates by affecting Nce103 expression.
What the sources say
- Supportedcites [27] Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011). source
The citation identifies the IGV tool used by the citing authors, rather than attributing their RCA1 finding to the source. In “To the Editor,” the source describes developing IGV and explains how it displays putative SNPs and supports visual assessment of variants. (LLM, conf=0.93)
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thus, CSP is particularly important during early culture stages at low cell densities, when metabolism-derived CO2 is insufficient to support growth37.”
§ Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103 > Results > The CSP is required for fungal fitness and colonization of nutrient-limited skin niches
What the sources say
- Partly supportedcites [37] Hall, R. A. et al. CO2 acts as a signalling molecule in populations of the fungal pathogen Candida albicans. PLOS Pathog. 6, e1001193 (2010). sourceExperimental — accuracy not yet measured
The Results section (‘C. albicans-generated CO2 accumulates under diffusion-limiting conditions’; page unavailable) says carbonic anhydrase is essential for meeting metabolic demands at ambient CO2 and that sufficient self-generated CO2 can restore growth when its diffusion is limited. This supports the claim’s low-CO2 growth rationale, but the paper does not specifically establish that the CSP is particularly important during early culture stages at low cell densities. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
83 more claims · 4 with their cited sources checked
Create a free account to see all 169 claims and every source verdict.
- Probably not a substantial claim. 36
- It may state two separate claims as one. 55
- The quote only partly states this claim. 1
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“40.2 62 .”
InfluentialRobinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
(2021) · doi:10.1016/j.xinn.2021.100141 · Cited by 12,455
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Perez-Riverol, Y., Bai, J., Bandla, C., García-Seisdedos, D., Hewapathirana, S., Kamatchinathan, S., Kundu, D. J., Prakash, A., Frericks-Zipper, A., Eisenacher, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1038 · Cited by 6,125
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · cited 3×
“However, the CRISPR– Cas9 (clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9) method 33 allowed for constructing the nce103 Δ deletion when supplementing with 10% CO 2 .”
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806 · cited 1×
“9) 53,54 .”
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 6×
“Hence, we hypothesized that proteomics may identify key pathways involved in C. auris MDR traits from differentially abundant proteins (DAPs).”
InfluentialSelf-citationSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381
Chowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750 · cited 2×
“Since 2009, C. auris has spread to more than 50 countries, causing outbreaks in intensive care units and nursing homes 4,5 .”
Self-citation
Research works printed but not linked: 2
- Trinh, P.-C., Duc-Minh, N.-L., Phuc-Loi, L., Narakorn, K. & Karl, K. Rapid in vitro evolution of flucytosine resistance in Candida auris. mSphere 0, e0097724 (2025).
- Trinh, P.-C., Tamires, B. & Karl, K. Gene dosage of PDR16 modulates azole susceptibility in Candida auris. Microbiol. Spectr. 0, e0265924 (2025).
Cited by
The emerging pathogen Candida auris: host interactions and disease drivers
Sanya, D. R. A., Arevalo, A. V., Onésime, D., & Nobile, C. J. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01230-5 · Cited by 6
“Notably, within cutaneous microenvironments, hospital-associated bacterial pathogens such as Proteus mirabilis and Klebsiella pneumoniae produce carbon dioxide via urease activity, indirectly promoting C. auris fitness and dermal colonization [75] .”
Pathogenicity and virulence of Candida auris
Phan-Canh, T., Seiser, S., Chauhan, M., Kuchler, K., Chauhan, N., & Elbe‐Bürger, A. (2026) · Virulence · doi:10.1080/21505594.2026.2707827 · Cited by 7
“Comparative analyses of fermentative vs oxidative metabolism across Candida spp. may therefore help define metabolic traits that are uniquely associated with C. auris [57].”
InfluentialSelf-citationCytochrome bc1 Catalytic Subunit Rip1 Modulates Antifungal Tolerance in Candida auris
Phan-Canh, T., Lackner, M., Chauhan, M., Zenz, L.-M., Chauhan, N., & Kuchler, K. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c01058 · Cited by 1
Self-citationVaccaro, A., Cooper, J. F., Rodríguez, A. V., Badali, H., Kean, R., Ramage, G., & Lopez-Ribot, J. L. (2026) · Journal of Fungi · doi:10.3390/jof12040247 · Cited by 4
“It is hypothesized that bacterial urease activity, which releases CO 2 , improves C. auris fitness on the skin [96].”
Negi, P., Verma, N., Rishi, P., Multani, K., Sharma, M., Kumari, S., & Raj, K. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04864-z · Cited by 1
“This adapta - tion is frequently enhanced by bacterial skin commen-sals (such as Proteus mirabilis ) by hydrolysing urea in sweat to release CO 2 (Phan-Canh et al. 2025).”
Metadata
- Authors
- Phan-Canh, T., Coman, C., Lackner, M., Troppmair, N., Müller, C., Cerbu, D., Seiser, S., Penninger, P., Tsymala, I., Khunweeraphong, N., Bitencourt, T., Knarr, A., Jenull, S., Arzani, H., Zenz, L.-M., Ianiri, G., Chen, W., Chowdhary, A., Mobley, H. L. T., Hartl, M., Moser, D., Ahrends, R., Elbe-Bürger, A., & Kuchler, K.
- Affiliations
- Max Perutz Labs (AT)
- University of Vienna (AT)
- Innsbruck Medical University (AT)
- Ludwig-Maximilians-Universität München (DE)
- Medical University of Vienna (AT)
- University of Molise (IT)
- University of Delhi (IN)
- University of Michigan (US)
- Corresponding author
- Kuchler, Karl
- ORCID
- Phan-Canh, Trinh
- Coman, Cristina
- Lackner, Michaela
- Troppmair, Nina
- Müller, Christoph
- Cerbu, Diana
- Seiser, Saskia
- Penninger, Philipp
- Tsymala, Irina
- Khunweeraphong, Narakorn
- Bitencourt, Tamires
- Jenull, Sabrina
- Arzani, Hossein
- Ianiri, Giuseppe
- Chowdhary, Anuradha
- Mobley, Harry L. T.
- Hartl, Markus
- Moser, Doris
- Ahrends, Robert
- Elbe-Bürger, Adelheid
- Kuchler, Karl
- Venue
- Nature Microbiology
- Published
- 2025-12-23
- Volume
- 11
- Issue
- 2
- Pages
- 461-475
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC12872442
- OpenAlex
- W7116827782
- Cited by
- 16
- References
- 72
- Citations by year
- 2026: 16
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Microbiology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, skin colonization, amphotericin B resistance, bicarbonate, mitochondrial bioenergetics, EFG1, urease, antifungal resistance, resensitization
- MeSH terms
- Candida auris, Amphotericin B, Antifungal Agents, Candidiasis, Carbon Dioxide, Carbonic Anhydrases, Fungal Proteins, Humans, Skin, Tropism, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103. https://app.cochat.ai/papers/10.1038/s41564-025-02189-z
- The paper
- Phan-Canh, T., Coman, C., Lackner, M., Troppmair, N., Müller, C., Cerbu, D., Seiser, S., Penninger, P., Tsymala, I., Khunweeraphong, N., Bitencourt, T., Knarr, A., Jenull, S., Arzani, H., Zenz, L.-M., Ianiri, G., Chen, W., Chowdhary, A., Mobley, H. L. T., . . . Kuchler, K. (2025). Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103. Nature Microbiology. https://doi.org/10.1038/s41564-025-02189-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.